Rational use of cetuximab in the treatment of advanced non-small cell lung cancer
Charu Aggarwal, Hossein BorghaeiDepartment of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USAAbstract: Lung cancer is the leading cause of mortality in the United States. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. Most NSCLC patients prese...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-08-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | http://www.dovepress.com/rational-use-of-cetuximab-in-the-treatment-of-advanced-non-small-cell--a3493 |